ECG interpretation in athletes

ECG is very useful for early identification of causes of sudden cardiac death in athletes such as cardiomyopathy, primary electrical diseases.

This interpretation becomes even more difficult in athletes where normal physiologic changes related to athletic training (Athlete's heart)  have to be distinguished from pathologic changes. 

In 2012 a summit met at Seattle and put together a group of criteria to distinguish Athlete's heart form a pathological ECG findings (check out article at pubmed link http://www.ncbi.nlm.nih.gov/pubmed/23303758). The group discussed about
1. Normal ECG findings in athletes
2. Abnormal findings in cardiomyopathy
3. Abnormal findings in primary electrical 


The above table is taken from the Seattle criteria guideline. 
Check out the table below which gives you a great summary of abnormal ECG findings




Comments

Post a Comment

Popular posts from this blog

Image
Ebstein's anomaly risk of anomaly 1 in 20,000 higher frequency in mothers who take lithium tricuspid valve leaflet anterior leaflet - largest leaflet and attached to valve annulus, large, redundant posterior and septal leaflet- vestigial/ absent - (failure of delamination of leaflets) when present the leaflets free edges are generally displaced posteriorly and downwards from AV junction and progressively towards the RVOT RV the RV i divided into two parts - proximal part - atrialized RV and distal part is RV proper and is small Different classifications to describe Ebstein's - type I--> IV (IV is the worst) Associated cardiac defects - ASD, PFO, VSD, PDA, RVOTO, Coarctation, WPW, LVNC Differential diagnosis of Ebstein's - tricuspid valve dysplasia - tricuspid valve prolapse - TV endocarditis - carcinoid heart disease - Uhl's anomaly - ARVC EKG findings RAE, RVH, RBBB, pre-excitation ECHO - TV displacement >0.8cm/m^2 of BSA com
Read more

Newest CDC recommendations for gonorrhea

Image
Based on GISP data, CDC recommends combination therapy with ceftriaxone 250 mg intramuscularly and either azithromycin 1 g orally as a single dose or doxycycline 100 mg orally twice daily for 7 days as the most reliably effective treatment for uncomplicated gonorrhea. CDC no longer recommends cefixime at any dose as a first-line regimen for treatment of gonococcal infections. If cefixime is used as an alternative agent, then the patient should return in 1 week for a test-of-cure at the site of infection Link to website with the above recommendations
Read more